Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2011; 32(02): 76-81
DOI: 10.4103/0971-5851.89776
ORIGINAL ARTICLE

Isolated primary extranodal lymphoma of the oral cavity: A series of 15 cases and review of literature from a tertiary care cancer centre in India

Gunjan H Shah
Departments of Head & Neck Oncology and Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
,
Sajid Khan Panwar
Departments of Head & Neck Oncology and Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
,
Pankaj P Chaturvedi
Departments of Head & Neck Oncology and Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
,
Shubhada N Kane
Departments of Head & Neck Oncology and Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
› Author Affiliations Source of Support Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Background: Non-Hodgkin′s lymphomas (NHL) have a great tendency to affect organs and tissues that do not ordinarily contain lymphoid cells. Involvement of the oral cavity by NHL is very rare. Materials and Methods: Retrospective analysis was carried out by chart review of patients who presented to our hospital between 1990 and 2008. All those patients whose histopathology at our hospital was confirmed as lymphoma were included. Results: Although we register nearly 2000 new oral cancers every year, most of which are squamous cell cancers, we could trace only 15 cases of oral lymphoma in the last 18 years. Of these, hard palate and alveolus were most common sites (5 each). The median age at presentation was 42.6 years. A vast majority (12/15) were NHL. Most patients (70%) reported with painless progressive swelling without systemic signs, such as fever, weight loss, and so on. Only 2 patients were HIV positive. Nearly two thirds received combinations of CT and RT. Cyclophosphamide, hydroxydaunorubicin, oncovin (vincristine), prednisolone regime was the most common regime offered (12/15). Most of them (67%) had good response to 6 cycles of CT that was followed by RT. 10/15 patients completed treatment. Follow-up data of more than 2 years of follow-up was present in 11/15 patients. With median follow-up of 27 months, 5 were disease free, 5 died, and 1 controlled following 2nd line of CT, 2 were lost to follow-up and 2 were alive with disease. Discussion: Head and neck lymphoma is the second most common region for extranodal lymphoma. The nasopharynx, tonsils, and base tongue are most often involved. Unlike the western world, oral cavity involvement is extremely rare. Interestingly, only 2 patients tested positive for HIV and most were young patients. Oral lymphoma may mimic benign oral conditions that often lead to misdiagnosis. Conclusion: Although oral cavity may be the preferred site of NHL in immunocompromised patients it does occur in immunocompetent patients as well. Isolated oral lymphoma is extremely rare and from our data we can say that oral NHL in Indian sub population is more aggressive compared with western literature.

Keywords

Chemotherapy - hard palate and alveolus - non-Hodgkin′s lymphoma - oral cavity - radiotherapy


Publication History

Article published online:
06 August 2021

© 2011. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Van der Waal RI, Huigens PC, Van der VP, Van der Waal I.Characteristics of 40 primary extranodal non-Hodgkin′s lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg 2005;34:391-5.
  • 2 Chan JK. The new World Health Organization classification of lymphomas: The past, the present and the future. Hematol Oncol 2000;19:129-50.
  • 3 Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P.Extranodal lymphomas of the head and neck: A 20 year experience. Arch Otolaryngol head Neck Surg 1997;123:1318-23.
  • 4 Kobler P, Borcic J, Filipovic ZI, Nola M, Sertic D. Primary non-Hodgkin′s lymphoma of the oral cavity. Oral Oncology Extra 2005;41:12-4.
  • 5 Jayakrishnan R, Thomas G, Kumar A, Nair R. Non-Hodgkin′s lymphoma of the hard palate. J Oral Maxillofac Pathol 2008;12:85-7.
  • 6 Yin HF, Jamlikhanova V, Okada N, Takagi M. Primary natural killer/T-cell lymphomas of the oral cavity are aggressive neoplasms. Virchows Arch 1999;435:400-6.
  • 7 Ramani P, Ahmed S, Janaki VR. Primary non-Hodgkin′s lymphoma of the oral cavity. Indian J Dematol Venereol Leprol 2004;70:172-4.
  • 8 Isaacson P, Wright DH. Malignant Lymphoma of Mucosa-Associated Lymphoid Tissue - A Distinctive Type of B-Cell Lymphoma. Cancer 1983;52:1410-6.
  • 9 AlShemmari SH, Ameen RM, Sajnani KP. Extranodal lymphoma: A comparative study. Hematology 2008;13:163-9.
  • 10 Sargeant KP, Grider DJ, Eagan PA, Davey DD, Damm DD, Robinson RA, et al. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus Gulley M. L; Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics ISSN 1079- 2104 Source / Source Congrès American Academy of Oral Medicine. Vol.80. Annual meeting 1995. p. 420-31.
  • 11 Halilbasic A, Mesic E, Cikusic E, Arnautovic A. Non Hodgkin lymphoma in the north east Bosnia- changes in biological aggressiveness and primary presentation of the disease, Med Arh 2006;60:78-83.
  • 12 Sankaranarayan S, Chandrasekar T, Rao PS. Maxillary Non- Hodgkin lymphoma. J Oral Maxillofac Pathol 2005;9:34-6.
  • 13 Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, et al. Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection. Blood 1997;89:1413-20.
  • 14 Hicks MJ, Flaitz CM, Nicholas CM, Luna MA, Gresik MV. Intraoral presentation of anaplastic large cell Ki-l lymphoma in association with HIV infection. Oral Surg Oral Med Oral Pathol 1993;76:73-81.
  • 15 Wood NH, Feller L, Raubenheimer EJ, Jadwat Y, Meyerov R, Lemmer J. Human immunodeficiency virus (HIV)-associated extranodal T cell non-Hodgkin lymphoma of the oral cavity. SADJ 2008;63:158-61.
  • 16 Ferlay J, Bray F, Pisani P, Parkin DM (2001). GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0 IARC cancer Base No. 5. Lyon: IARC, 2001.
  • 17 Hashimoto N, Kurihara K. Pathological characteristics of oral lymphomas. J Oral Pathol 1982;11:214-27.
  • 18 Maheshwari GK, Baboo HA, Gopal U, Wadhawa MK. Primary extra-nodal non-Hodgkin′s lymphoma of the cheek. J Postgrad Med 2000;46:211-2.
  • 19 Maheshwari GK, Baboo HA. Primary non-Hodgkin lymphoma of the oral tongue. Turkish J Cancer 2001;31:121-4.
  • 20 Pazoki A, Jansisyanont P, Ord RA. Primary non-Hodgkin′s lymphoma of the jaws: Report of 4 cases and review of the literature. J Oral Maxillofac Surg 2003;61:112-7.
  • 21 Enrique A, Quesada JL, Lorente J, Lopez D. Hodgkin and non-Hodgkin lymphomas in ENT. Acta Otorhinolaringol Esp 2004;55:387-9.
  • 22 Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML,et al. A revised European American classification of lymphoid neoplasms: A proposal from the international study lymphoma group. Blood 1994;84:1361-92.
  • 23 Harris NL, Jaffe ES, Stein H, Vardiman JW. World Health Organisation Classification of Tumours. Pathology and genetics of tumours of the haemopoetic and lymphoid tissues. IARC press, Lyon: 2001.
  • 24 Carbone PP, Kaplan HS, Musshof K, Smithers DW, Tubiana M.Report of the committee on Hodgkin′s disease staging classification. Cancer Res 1971;31:1860-1.
  • 25 Hermans J, Krol AD, Van GK, Kluin PM, Kluin-Nelemans JC, Kramer MH, et al. International prognostic index for aggressive non-Hodgkin′s lymphoma is valid for all malignancy grades. Blood 1995;86:1460-3.
  • 26 NCI sponsored study of classification of non-Hodgkin lymphomas: Summary and description of a working formulation for clinical usage. The non-Hodgkin lymphoma pathological classification project. Cancer 1991;49:2112-35.
  • 27 Rappaport H. Tumours of the hemopoetic system. Atlas of tumour pathology Section 3rd, fascicle 8, Washington DC: Armed Forced Institute of Pathology; 1966.
  • 28 Leukes RJ, Collins RO. Immunologic characteristics of human malignant lymphoma. Cancer 1974;34:1488-5030
  • 29 Hicks MJ, Flaitz CM. External root resorption of a primary molar: incidental Histopathological finding of clinical significance, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:4-8.
  • 30 Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M, et al. CD20-negative large-cell lymphoma with plasmablastic features: A clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004;15:1673-9.
  • 31 Wolvius EB, Van Der VP, Van Der WJE, Van Diest PJ, Huijgens PC, Van Der WI, et al. Primary extranodal non- Hodgkin′s lymphoma of the oral cavity An analysis of 34 cases. Eur J Cancer B Oral Oncol 1994;30:121-5.
  • 32 Gustavsson A, Osterman B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in non-Hodgkin′s lymphoma. Acta Oncol 2003;42:605-19.
  • 33 Yokobayashi Y, Nkajima T, Fikushima M, Ishiki T. Non- Hodgkin′s lymphoma of the gingival: A case report. Int J Oral Surg 1981;10:359-62.
  • 34 Spina M, Tirelli U. HIV-related non-Hodgkin′s lymphoma (HIV-NHL) in the era of highly active antiretroviral therapy (HAART): Some still unanswered questions for clinical management. Ann Oncol 2004;15:993-5.
  • 35 Slootweg PJ, Wittkampf AR, Kluin PM, de Wilde PC, van Unnik JA. Extranodal non-Hodgkin′s lymphoma of the oral tissues. An analysis of 20 cases J Maxillofac Surg 1985;13:85-92.
  • 36 Eisenbud L, Scibba, Mir R, Sachs SA. Oral presentation in non-Hodgkin′s lymphoma: A review of 31 cases. Part I. Data analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1983;56:151-6.
  • 37 Al-Soudani KA, Matukas VJ. Malignant lymphoma of the palate: Report of two cases. J Oral Maxillofac Surg 1986;44:811-4.
  • 38 Takashashu H, Tezuka F, Fujita S, Okabe H. Primary extranodal malignant non-Hodgkin′s lymphoma of oral cavity. J Oral Pathol 1987;16:242-50.
  • 39 Howell RE, Handlers JP, Abrams AM, Melrose RJ. Extranodal oral lymphoma. Part II. Relationships between clinical features and the Lukes-Collins classification of 34 cases. Oral Surg Oral Med Oral Pathol 1987;64:597-602.
  • 40 Fukada Y, Ishida T, Fujimoto M, Ueda T, Aozasa K. Malignant lymphoma of the oral cavity: Clinicopathologic analysis of 20 cases. J Oral Pathol 1987;6:8-12.
  • 41 Bachaud JM, Coppin D, Douchez J, Boutault F, Paty E, Saboye J,et al. Primary malignant lymphoma of the mandible. A study of 3 cases and a review of the literature. Rev Stomatol Chir Maxillofac 1992;93:372-6.
  • 42 Lozada-Nur F, de Sanz S, Silverman S Jr, Miranda C, Regezi JA.Intraoral non-Hodgkin′s lymphoma in seven patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:173-8.
  • 43 Landa-Llona S, Perez-Nievas I, Montes GE, Ereno-Zarate C, Pereda-Martinez E, Barbier-Herrero L, et al. Maxillary non Hodgkin′s lymphoma. A report of two clinical cases and review of the literature. Med Oral 1998;3:299-308.
  • 44 Nocini P, Lo Muzio L, Fior A, Staibano S, Mignogna MD. Primary non-Hodgkin′s lymphoma of the jaws: Immunohistochemical and genetic review of 10 cases. J Oral Maxillofac Surg 2000;58:636-44.
  • 45 Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: A population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:519-25.
  • 46 Kolokotronis A, Konstantinou N, Christakis I, Papadimitriou P,Matiakis A, Zaraboukas T, et al. Localized B-cell non- Hodgkin′s lymphoma of oral cavity and maxillofacial region: A clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:303-10.
  • 47 Djavanmardi L, Oprean N, Alantar A, Bousetta K, Princ G. Malignant non-Hodgkin′s lymphoma (NHL) of the jaws: A review of 16 cases. J Craniomaxillofac Surg 2008;36:410-4.